Markets:

Overview

News

Currencies

International

Treasuries

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

21.84 -0.42 (-1.89%)

Streaming Delayed Price Updated: 12:35 PM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sarepta Therapeutics, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

33 34 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 25, 2023

Via Benzinga

Sarepta Therapeutics to Announce Third Quarter 2023 Financial Results

October 25, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 24, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 19, 2023

Via Benzinga

5 Analysts Have This to Say About Sarepta Therapeutics ↗

September 26, 2023

Via Benzinga

Is Sarepta Therapeutics Stock a Top Growth Vehicle? ↗

August 23, 2023

An upcoming data readout could fuel another rally in the biotech's shares.

Via The Motley Fool

Analyst Ratings for Sarepta Therapeutics ↗

August 03, 2023

Via Benzinga

3 Gene Editing Stocks to Generate Super-Charged Gains ↗

October 18, 2023

As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

October 10, 2023

Via Benzinga

Sarepta Therapeutics Stock Showing Rising Relative Strength ↗

October 09, 2023

Sarepta Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Via Investor's Business Daily

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 29, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

Earnings Preview: Sarepta Therapeutics ↗

August 01, 2023

Via Benzinga

2 Biotech Growth Stocks I'd Buy Right Now ↗

July 27, 2023

Both drugmakers seem to have a bright future ahead.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2023

Via Benzinga

Are Gene Therapy Stocks The Market's Next Big Winners?

September 25, 2023

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

Via MarketBeat

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 15, 2023

Via Benzinga

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point? ↗

September 15, 2023

Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 14, 2023

Via Benzinga

2 Top Growth Stocks to Buy With $500 ↗

September 14, 2023

No need to break the bank to invest in stocks.

Via The Motley Fool

Insiders Are Buying These 2 Stocks

September 08, 2023

Insider buying in both Loews (NYSE: L) and Sarepta (NASDAQ: SRPT) suggests a positive outlook for these stocks, potentially influencing investor sentiment.

Via MarketBeat

Sarepta Therapeutics Announces Recipients of the 6th Annual Route 79, The Duchenne Scholarship Program, for the 2023-2024 Academic Year

September 07, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

Sarepta Therapeutics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

September 05, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 31, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation ↗

August 22, 2023

Helping save and improve patients' lives in novel ways can be a lucrative activity.

Via The Motley Fool

Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

August 15, 2023

Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades.

Via Benzinga

$3M Bet On Tidewater? Check Out These 4 Stocks Insiders Are Buying ↗

August 14, 2023

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Via Benzinga

Sarepta Therapeutics (SRPT) Q2 2023 Earnings Call Transcript ↗

August 02, 2023

SRPT earnings call for the period ending June 30, 2023.

Via The Motley Fool

Sarepta Therapeutics Announces Second Quarter 2023 Financial Results and Recent Corporate Developments

August 02, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 31, 2023

From Sarepta Therapeutics, Inc.

Via Business Wire

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.